Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients.
He R, Chiou J, Chiou A, Chen D, Chen CP, Spethman C, Bessonen KR, Oliveira JL, Nguyen PL, Reichard KK, Hoyer JD, Althoff SD, Roh DJ, Miller MA, Yuan J, Olteanu H, Begna K, Tefferi A, Alkhateeb H, Patnaik MM, Litzow MR, Al-Kali A, Viswanatha DS.
He R, et al. Among authors: hoyer jd.
Blood Cancer J. 2022 Jan 25;12(1):12. doi: 10.1038/s41408-022-00612-w.
Blood Cancer J. 2022.
PMID: 35078969
Free PMC article.
No abstract available.